港股異動 | 兑吧(1753.HK)大漲超16% 較5月低點已反彈超1.5倍
格隆匯7月31日丨兑吧(1753.HK)午後大漲16.18%,報4.02港元,暫成交1.1億港元,最新總市值43億港元。該股自5月中旬以來持續上漲,現價較5月15日盤中低點1.59港元已反彈超1.5倍。據悉,為解決保險企業線上運營投入大、週期長、自建困難等痛點,兑吧基於多年線上運營經驗沉澱,為保險行業打造專屬解決方案。兑吧保險行業解決方案結合傳統保險和互聯網保險的特點,幫助保險公司實現用户運營數字化轉型,靈活應對市場的變化,多方位高效運營各階段用户,大大降低保險公司IT運營成本,成為保險公司線上經營的堅強後盾。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.